Introduction
This quiz-focused blog covers preclinical screening principles specifically on dose selection and interspecies dose conversions — essential topics for M.Pharm students preparing for pharmacology and toxicology roles. You will find clear explanations and targeted multiple-choice questions that reinforce concepts such as NOAEL, MTD, LD50, HED calculation using Km/BSA, allometric scaling, MABEL, MRSD and safety factors. The questions are designed to test applied understanding: converting animal doses to human equivalents, choosing appropriate starting doses for first-in-human studies, and appreciating limitations of simple mg/kg scaling. Use this set to sharpen decision-making for preclinical dose selection and regulatory-relevant calculations.
Q1. What does NOAEL stand for in toxicology studies?
- No Observed Adverse Effect Level — the highest dose at which no adverse effects are observed
- New Observed Adverse Effect Limit — a newly discovered toxic threshold
- Normal Observed Activity and Effect Level — typical observed activity in controls
- Non-Observed Activity Exposure Limit — a minimal exposure limit
Correct Answer: No Observed Adverse Effect Level — the highest dose at which no adverse effects are observed
Q2. What is the Maximum Tolerated Dose (MTD) defined as?
- The lowest dose causing any biological effect
- The dose that causes death in 50% of animals
- The highest dose that does not cause unacceptable toxicity
- The recommended clinical starting dose for humans
Correct Answer: The highest dose that does not cause unacceptable toxicity
Q3. LD50 refers to which of the following?
- Lowest dose producing 50% of maximal therapeutic effect
- Median lethal dose that kills 50% of the test animals
- Lowest detectable dose in a bioassay
- Limit dose used in chronic toxicity studies
Correct Answer: Median lethal dose that kills 50% of the test animals
Q4. Which formula correctly converts an animal dose (mg/kg) to a human equivalent dose (HED, mg/kg) using Km factors?
- HED (mg/kg) = Animal dose (mg/kg) × (Human Km / Animal Km)
- HED (mg/kg) = Animal dose (mg/kg) × (Animal Km / Human Km)
- HED (mg/kg) = Animal dose (mg/kg) ÷ (Animal Km × Human Km)
- HED (mg/kg) = Animal dose (mg/kg) + (Animal Km − Human Km)
Correct Answer: HED (mg/kg) = Animal dose (mg/kg) × (Animal Km / Human Km)
Q5. What is the standard Km value commonly used for an adult human (60 kg) in BSA-based conversions?
- 3
- 6
- 20
- 37
Correct Answer: 37
Q6. Which of the following approximate Km values is used for a mouse?
- 37
- 20
- 6
- 3
Correct Answer: 3
Q7. Convert a mouse dose of 50 mg/kg to HED (mg/kg) using Km(mouse)=3 and Km(human)=37. What is the approximate HED?
- ≈0.74 mg/kg
- ≈4.05 mg/kg
- ≈15.0 mg/kg
- ≈62.3 mg/kg
Correct Answer: ≈4.05 mg/kg
Q8. The Maximum Recommended Starting Dose (MRSD) for first-in-human studies is typically derived by:
- Using the animal LD50 converted to humans without safety factors
- Converting animal NOAEL to HED and dividing by an appropriate safety factor
- Directly applying the highest efficacious animal dose (mg/kg) to humans
- Using only in vitro potency (IC50) values
Correct Answer: Converting animal NOAEL to HED and dividing by an appropriate safety factor
Q9. What does MABEL stand for and why is it used?
- Maximum Anticipated Biological Effect Level — to determine toxic dose limits
- Minimum Anticipated Biological Effect Level — to select very conservative starting doses based on pharmacology
- Median Anticipated Benefit/Efficacy Level — to estimate therapeutic window
- Measured Animal Bioequivalent Level — to compare animal and human exposures
Correct Answer: Minimum Anticipated Biological Effect Level — to select very conservative starting doses based on pharmacology
Q10. Allometric scaling commonly uses which exponent relating physiological parameters to body weight?
- 0.25
- 0.50
- 0.75
- 1.00
Correct Answer: 0.75
Q11. How is the Therapeutic Index (TI) typically calculated?
- ED50 divided by LD50
- LD50 divided by ED50
- NOAEL divided by MTD
- HED divided by animal dose
Correct Answer: LD50 divided by ED50
Q12. For a highly potent biologic with receptor-mediated effects, which approach is generally preferred to select a safe first-in-human dose?
- Use only animal LD50 converted by BSA
- Use the Minimum Anticipated Biological Effect Level (MABEL)
- Use the highest animal efficacious dose directly scaled by mg/kg
- Use historical human doses of small molecules
Correct Answer: Use the Minimum Anticipated Biological Effect Level (MABEL)
Q13. Convert a rat dose of 10 mg/kg to HED (mg/kg) using Km(rat)=6 and Km(human)=37. What is the approximate HED?
- ≈0.62 mg/kg
- ≈1.62 mg/kg
- ≈6.17 mg/kg
- ≈61.7 mg/kg
Correct Answer: ≈1.62 mg/kg
Q14. Which conversion method better accounts for interspecies differences in metabolic rate when scaling doses?
- Simple mg/kg scaling
- Body Surface Area (BSA)-based conversion using Km
- Using only in vitro IC50 values
- Converting by animal age instead of weight
Correct Answer: Body Surface Area (BSA)-based conversion using Km
Q15. Which of the following is LEAST relevant for scientific preclinical dose selection?
- Pharmacokinetic/pharmacodynamic (PK/PD) data
- Repeat-dose toxicology studies including NOAEL
- In vitro potency and target occupancy data
- Market launch price and marketing strategy
Correct Answer: Market launch price and marketing strategy
Q16. A common default safety factor applied when converting animal NOAEL-derived HED to a human starting dose is:
- 2
- 10
- 50
- 1000
Correct Answer: 10
Q17. In the Km approach, what does the Km value represent?
- The ratio of animal metabolic rate to human metabolic rate
- Species-specific factor equal to body weight (kg) divided by body surface area (m²)
- The fixed conversion factor from mg to µg for each species
- The average lifespan-adjusted dose multiplier
Correct Answer: Species-specific factor equal to body weight (kg) divided by body surface area (m²)
Q18. If a dog NOAEL is 10 mg/kg, Km(dog)=20 and Km(human)=37, what is the HED (mg/kg) from this NOAEL?
- ≈1.85 mg/kg
- ≈5.41 mg/kg
- ≈18.5 mg/kg
- ≈54.1 mg/kg
Correct Answer: ≈5.41 mg/kg
Q19. How is the safety margin (or therapeutic margin) commonly defined in preclinical assessment?
- Ratio of ED50 to LD50
- Difference between MRSD and HED
- Ratio of NOAEL (or toxic benchmark) to the intended therapeutic exposure
- Sum of NOAEL and ED50
Correct Answer: Ratio of NOAEL (or toxic benchmark) to the intended therapeutic exposure
Q20. What is a key limitation of simple mg/kg dose scaling when converting animal doses to humans?
- It accurately accounts for metabolic rate differences across species
- It ignores body surface area and metabolic scaling, potentially misestimating exposures
- It is always more conservative than BSA-based methods
- It is the regulatory preferred method for all drug classes
Correct Answer: It ignores body surface area and metabolic scaling, potentially misestimating exposures
